Objective: Although meningioma patients show deficits in objective cognitive functioning (OCF) measured with neuropsychological tests, subjective cognitive functioning (SCF) has received little attention. We investigate SCF from pre-to postsurgery and its associations with OCF, psychological, sociodemographic, and clinical characteristics. Conclusions: Meningioma patients experienced better SCF as compared with controls before and 3 months after surgery, which might be the result of phenomena related to disease and recovery. As the findings suggest that cognitive symptoms might increase later on, future studies should further investigate the course of SCF in meningioma patients. In clinical practice, measurements of SCF should be combined with those of OCF and psychological distress in order to determine whether and which interventions are needed.
| BACKGROUND
Although meningiomas do not grow from brain tissue but arise from the meninges covering the brain, they are referred to as brain tumors and account for approximately 37% of all primary brain and central nervous system tumors. 1 The far majority of meningiomas are benign tumors 1 that can be treated well and have a favorable long-term prognosis. 2 Current standard of care consists of neurosurgical resection of the tumor, which most likely relieves initial neurological deficits that result from mass effects of the tumor. 3 However, many patients are left with adverse outcomes, such as fatigue, 4 lower quality of life, 5 and/or impairments in objective cognitive functioning (OCF). [6] [7] [8] Although deficits in OCF in meningioma patients, as assessed by neuropsychological tests, have been demonstrated in several studies, [6] [7] [8] self-reported or subjective cognitive functioning (SCF) has received little attention. The few studies investigating SCF in heterogeneous, cross-sectional samples of brain tumor patients, also including meningioma patients, found high percentages of patients reporting cognitive problems. [9] [10] [11] However, a comparison of patients with normative data was lacking in these studies, except for the study of van der Vossen et al 12 that reported poor SCF in 23% of meningioma patients approximately 32 months after surgery.
Additionally, potential associations between SCF and OCF have not been evaluated in a sample of patients with meningioma only.
Prior studies in other neuro-oncological patient groups reported little to no associations between SCF and OCF. 11, 13 Instead, poor SCF was more related to anxiety, depression, and fatigue than to OCF. 11, 13 Poor SCF can affect many aspects of daily living, such as employment, social functioning, and quality of life.
14 SCF in meningioma patients has not been studied over time including assessments both before and after surgery. The present study examined SCF and changes therein among a sample of meningioma patients before and 3 and 12 months after surgery. Additionally, we examined associations of SCF with OCF, anxiety, and depression for each time point, and with sociodemographic and clinical characteristics for the 3-month follow-up. We hypothesized that meningioma patients would report lower SCF when compared with normative controls. Also, we expected an improvement of SCF in meningioma patients over time as well as SCF to be more related to anxiety and depression than to OCF. ) was segmented semiautomatically, followed by manual adjustments, from contrast-enhanced T1-weighted Magnetic Resonance Images with ITK-SNAP software. 20 The American Society of Anesthesiologists (ASA) score, determined pre-operatively by the anesthetist, was considered as a measure of overall health. 21 Psychotropic medication was defined as the use of anti-epileptic drugs, corticosteroids, opioids, benzodiazepines, antidepressants, or a combination of these.
| Subjective cognitive functioning
The Cognitive Failures Questionnaire (CFQ) was used to assess SCF. [22] [23] [24] The CFQ is a 25-item questionnaire that measures the frequency of self-reported everyday cognitive failures over a period of 4 weeks. Response options range from 0 (never) to 4 (very often).
23,24
Psychometric qualities for the Dutch version of the CFQ were accept- 25 Since some domains generated by CNS VS are calculated on the basis of the same test scores, we included a selection of seven cognitive domains in this study.
| Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS) was used to measure self-reported symptoms of anxiety (7 items) and depression (7 items). 26, 27 Answer options for each item range from 0 to 3, resulting in a score range of 0 to 21 for each subscale. Higher scores indicate higher symptoms. 26 The Dutch version of the HADS has good psychometric qualities, with a test-retest reliability of 0.89 and 0.86, and
Cronbach's α ranging from 0.71 to 0.86. 
| Norms and cutoff levels
Patients with more than 4 missing values on the CFQ were excluded from the analyses. On the basis of the normative data reported by Ponds et al, 23 patients' CFQ total scores were converted into z scores (M = 0, SD = 1). For OCF, individual z scores were calculated based on a Dutch normative sample, 28 corrected for age, sex, education, and practice effects. 29 Higher z scores reflect better SCF/OCF.
The cutoff for low levels of SCF and OCF was set at z ≤ −1.50; for anxiety and depression raw scores, the cutoff was set at 8 for each subscale. 26 The number of patients scoring above each cutoff point was counted. Statistical analyses were conducted using SPSS version 24.0. In order to decrease false discovery rate due to multiple testing, we used
Benjamini-Hochberg (BH) corrections. There were no significant differences regarding sociodemographic and clinical characteristics between the samples at different time points (P's > BH-corrected α of .005) ( Table 1 ).
| Comparison of group level SCF with normative data
Patients reported significantly better SCF as compared with controls at T0 and T3 (Glass's Δ respectively 0.57 and 0.46; Table 2 ). At T12, no significant difference was found between patients and normative controls.
| Changes in group level SCF
For the 24 patients who completed all three assessments, we found a significant effect of time of measurement ( F = 8.09, P = .002; Table 2 ).
Post hoc analyses showed a decrease in group level SCF from T0 to T12 (mean difference = −.088, P < BH-corrected α of .017).
| Individual levels of SCF
The majority of patients reported average-to-(very)high SCF at all time points. More particularly, 3.7%, 5.4%, and 14.0% of the patients reported very low SCF respectively at T0, T3, and T12 (Table 2) .
| Associations of SCF with OCF, patient, and psychological characteristics
Negative z scores for all OCF domains were found at all time points (z scores range = −0.30 to −1.23; Table 3 ). Mean scores and percentages of patients scoring above the cutoff on measures of OCF and HADS for each time point are shown in Table 3 .
SCF was significantly associated with anxiety at all time points, and with depression at T3 and T12, but not with measures of OCF (Table 3) , nor with sociodemographic or clinical characteristics at T3 (r's = −0.102 to 0.145, see Table S1 ; online only).
| Discussion
The present study investigated SCF and changes therein from pre-to 12 months postsurgery among meningioma patients both at group and individual patient level. Furthermore, associations of SCF with OCF, psychological, sociodemographic, and clinical characteristics were explored.
Meningioma patients reported better SCF as compared with normative controls both before and 3 months after surgery. The majority of patients reported average-to-(very)high SCF at all time points. This is remarkable given the high percentages of brain tumor patients with cognitive complaints found in previous studies. 9-11 Moreover, we found lower performance for all OCF domains at all time points, which is in line with several studies clearly demonstrating deficits in OCF among meningioma patients. [6] [7] [8] Methodological differences and limitations may underlie differences in findings between our study and previous research evaluating SCF, including heterogeneous cross-sectional samples of brain tumor FIGURE 1 Flowchart of patients. Note: CFQ, cognitive failures questionnaire; NPA, neuropsychological assessment patients 9-11 and lack of validated questionnaires. 9, 11 More importantly, most studies did not compare patients' scores to normative data, 9-11 which may result in an overestimation of cognitive complaints in these patients, as healthy controls generally also report complaints to some extent. Alternatively, the CFQ, as a generic instrument, might not be suitable in differentiating SCF between meningioma patients and controls. Van Rijsbergen et al 33 showed that a strokespecific questionnaire on SCF (ie, CLCE-24) was able to differentiate in SCF between stroke patients and controls, whereas the CFQ was not.
Our findings may be explained by some clinical phenomena related to the disease and its recovery. Initially, the disease and its treatment require adjustments of the patient's personal, social, and professional life, for example, passing along domestic chores and/or discontinuing work. During recovery from surgery, patients are (partly) disburdened from their daily roles and responsibilities. 34 This support may result in limited experience of cognitive complaints, as patients have not encountered possible problems (yet). 35 Moreover, when faced with changes in health status, patients might alter their internal standards and values, a phenomenon known as response shift. 36 Initial beliefs about (poor) SCF might be reconsidered and evaluated differently given changes in health status (ie, diagnosis) and/or current functioning. Furthermore, patients' main concerns may be with issues other than SCF, resulting in little attention for and recognition of possible cognitive complaints. Lack of awareness of one's own cognitive functioning could also play a role, resulting from for instance psychological factors, such as denying cognitive deficits and/or from frontal lobe dysfunction. 37 In about half of the included patients in this study, the meningioma was located frontally; however, we did not find an association between frontal localization and SCF. It should be noted that most of the phenomena described may also apply to other neurological patients, which should be investigated in future studies.
On the longer-term, there was a significant decrease in SCF from baseline to 1 year after surgery in a subsample of patients. At that time-point, SCF was at a level comparable with normative controls.
One-year postsurgery, 14% of patients reported very low SCF as opposed to 3.7% and 9.1% before and 3 months after surgery. These long-term results appear to be in line with the findings of van der
Vossen et al 12 who found that 23% of the meningioma patients reported cognitive complaints, as measured with the CFQ, approximately 32 months post surgery. These researchers set a slightly higher population mean for normative purposes (32.5) but used a less stringent cutoff (1SD) for determining complaints, which might have resulted in a higher percentage of patients reporting complaints. However, studies among other neuro(onco)logical patient groups using the CFQ, 14, 38 solely including a long-term assessment, reported high levels of complaints years after diagnosis, suggesting the possibility that complaints, regardless of type of diagnosis, may manifest later on because of the (inability of) full resumption of daily activities at that time. As the follow-up period in the current study did not exceed In line with previous studies in neuro-oncological patient groups, 11,13 SCF was not related to OCF. Instead, close associations between SCF and anxiety and depression have been described, 11, 13 as was also the case in our meningioma sample. The lack of associations between SCF and OCF might be because of different assessment techniques: whereas SCF is often assessed using self-reported questionnaires (reflecting a broader period of time and different situations),
OCF is assessed at one point in time using neuropsychological measurements in a clinical setting. Neuropsychological tests can suffer from insufficient ecological validity and might therefore not reflect patients' (experience of) cognitive functioning in daily life. 39 
| Study limitations
Some study limitations should be considered. First, the number of data available differs between time points because of expansion of our research project, although we found no differences regarding patient characteristics between time points. Second, we solely included relatively well-functioning patients who were appropriate candidates for surgery, and who were also capable of filling out the CFQ and performing the NPA. On the other hand, patients with very small (less than 3 cm) meningioma (in absence of symptoms) adopt a wait-andscan approach or are treated with Gamma Knife radiosurgery in our hospital. Consequently, our results may not be representative for the general population of meningioma patients. In addition, although SCF is known to be related to fatigue, 4,13 we were not able to study this relationship in this sample for the 3-month time-point. However, a former study of our group, that included a partially overlapping sample of patients from the current study, demonstrated that substantial (mental) fatigue was very common prior to as well as 1 year after surgery. In clinical practice, to evaluate cognitive function, SCF should be assessed together with OCF, as patients' reports on their SCF does not allow conclusions about their OCF. The patients that do report poor SCF should also be screened for psychological symptoms, as poor SCF might be an indicator of emotional distress. In providing optimal care and in determining whether and which interventions (eg, cognitive rehabilitation or pharmaceutical agents 40 ) are needed the patient should be considered as part of a complex environment, taking psychological distress and social support into account.
| Clinical implications

